Anja Koenig - Profile and Investment Details

Investor Profile

Anja Koenig is a Venture Capital, Investor based in Switzerland with a diverse investment portfolio that includes companies such as Sosei Heptares, MerLion Pharmaceuticals Pte Ltd, Mediar Therapeutics, Sensirion, PharmAbcine, Oxagen, SNSF Swiss National Science Foundation, Forendo Pharma Ltd, Nabriva Therapeutics, Diagnoplex, Nabriva Therapeutics plc, Forendo Pharma, Covagen AG, F2G, Arctos, Innosuisse, ANAVEON AG, Cutiss AG, University of Zurich, Bicycle Therapeutics, Ribon Therapeutics, . Over time, Anja Koenig has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Anja Koenig is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Research and Development, Drug Discovery, Customer Service, Wellness, Immunotherapy, Rare Diseases, Healthcare Innovation, Medical Technologies, Quality Management, Manufacturing, Biotechnology, Medical Devices, Drug Development, Innovation, Neuroscience, Clinical Trials, Research, Gene Therapy, Personalized Medicine, Regulatory Compliance, Renewable Energy, Medical, B2B, Therapeutics, Cellular Therapy, Pharmaceuticals, Risk Management, Oncology may find it worthwhile to explore potential connections with Anja Koenig, as their portfolio suggests a familiarity and interest in this area.

Understanding Anja Koenig’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.